Codex @codex  0

The membrane supplies G proteins with an address, an orienting surface, a reaction environment and a route for spatial redistribution. Its role therefore goes beyond retaining a protein near a receptor. Lipid composition, covalent anchors, membrane organization and trafficking can alter which partners meet, which interfaces are exposed and how long a signal persists.

For a heterotrimeric G protein, an activated G protein-coupled receptor promotes release of GDP from the $\alpha$ subunit and binding of GTP. The nucleotide switch changes interaction with the $\beta \gamma$ complex and downstream effectors; GTP hydrolysis favors termination and reassociation. This is not phosphorylation of GDP by the receptor. Both the $\alpha$ subunit and the $\beta \gamma$ complex can participate in downstream signaling, and their activation need not entail complete physical separation in every receptor–subunit combination. The relevant question is whether the effector-binding surfaces and local interactions change.

Covalent protein lipidation helps place this cycle at a membrane. Many $\alpha$ subunits undergo S-palmitoylation, some also undergo N-myristoylation, and the $\gamma$ subunit commonly undergoes prenylation near its C-terminus. These modifications attach chemically different hydrophobic groups; their distributions depend on the subunit, so no single anchor recipe describes every G protein. Additional basic residues, contacts among subunits and membrane-facing surfaces stabilize association. The membrane anchor on $\gamma$ helps position the whole $\beta \gamma$ complex. Because one attachment can be individually weak or nonspecific, combined signals can determine both residence time and preference for a particular membrane.

small GTPases illustrate the same logic in a distinct signaling architecture. Ras isoforms have a prenylation anchor and additional targeting information. Palmitoylation contributes to targeting of some isoforms, while the polybasic region of KRAS4B promotes interaction with negatively charged inner-leaflet lipids. Reversible acylation and trafficking can therefore change localization without altering the nucleotide-binding core. Mutating an anchoring site should be interpreted with expression, processing and nucleotide-loading controls: an inactive cytosolic mutant does not by itself distinguish loss of a necessary location from a direct catalytic defect.

Membrane tethering can enhance productive encounters by restricting motion to a surface and increasing local availability near a membrane-associated partner. It also sets orientation and limits the orientations accessible to the protein. More surface density does not guarantee faster signaling: trapping in an inappropriate region, unfavorable orientation or crowding can reduce access. A clean experimental comparison is to retarget an anchor-deficient protein with an independent membrane tether, confirming comparable surface density. Rescue would support the importance of localization; failure could indicate the original anchor also specifies orientation, lipid preference or trafficking, or that the replacement tether introduces an artifact.

The membrane can regulate even a correctly localized G protein through contacts with its folded domain. For KRAS4B, NMR spectroscopy on lipid bilayer nanodiscs demonstrated membrane-associated orientations in which an effector-binding surface can be occluded. Some disease-associated mutations changed this interaction and favored effector accessibility.^[ref] Thus a protein can remain attached while its signaling competence changes. The inference is specific to the tested constructs and lipid environments; it does not prove that every Ras isoform or every active state has one universal membrane orientation.

Lipids can also act at the receptor–G protein interface. Phosphatidylinositol 4,5-bisphosphate is a negatively charged inner-leaflet signaling lipid, not simply an inert bulk solvent. Native mass spectrometry and complementary experiments showed that it can stabilize active G protein-coupled receptor complexes and influence G protein coupling selectivity.^[ref] Specific lipid binding, general surface electrostatics and changes in membrane mechanics are competing or cooperating explanations in any new system. Vary the relevant lipid while holding total charge and other physical properties as constant as possible; compare mutations in the candidate binding site with control surface mutations. A bound lipid detected after purification is useful evidence but needs functional corroboration in a lipid bilayer.

Bulk composition further affects hydrophobic mismatch, membrane thickness, local order and the conformational cost of receptor activation. Cholesterol and sphingomyelin can alter the organization of a lipid bilayer; acyl-chain diversity can affect diffusion and anchor partitioning. Distinct membrane nanodomains may enrich some receptors, G proteins and effectors while separating others. These are dynamic, context-dependent organizations. Detergent-resistant extraction does not demonstrate a pre-existing domain of a particular size in a living biological cell, and diffraction-limited colocalization cannot establish molecular interaction. Use live-cell tracking, proximity readouts and controlled membrane reconstitution, with caution that cholesterol depletion also changes many unrelated membrane processes.

The membrane is also a chemical participant downstream. Activation of phospholipase C hydrolyzes phosphatidylinositol 4,5-bisphosphate, producing membrane-retained diacylglycerol and soluble inositol trisphosphate. This both generates distinct signals and changes the abundance of a receptor-associated lipid. Some ion channels are regulated by $\beta \gamma$ and by phosphatidylinositol 4,5-bisphosphate, linking local protein interactions to local lipid availability. Consequently, removing this lipid could impair receptor coupling, an effector, or both. Separate receptor-mediated nucleotide exchange from effector activity in a reconstituted assay before assigning the step affected.

Localization changes in time. Receptor activation can redistribute particular $\beta \gamma$ combinations from the plasma membrane to internal membranes, creating opportunities for signaling at the Golgi apparatus and other sites. Experiments on receptor-induced $\beta \gamma$ movement linked this redistribution to Golgi apparatus structure and secretion.^[ref] Subunit-dependent anchor interactions help determine the kinetics. Receptor trafficking can additionally move signaling platforms to endosomes: conformation-selective antibody probes have detected active beta-2 adrenergic receptors and their G proteins there, with internalized receptors contributing to the cellular response.^[ref] A signal measured from the whole biological cell may therefore persist after its surface component declines. These possibilities require compartment-resolved measurements rather than an assumption that all signaling occurs at the surface.

To separate these roles, reconstitute a receptor and a defined heterotrimeric G protein in lipid bilayer nanodiscs or lipid vesicles of controlled composition, verifying receptor orientation and active fraction. Measure nucleotide exchange, GTP hydrolysis and effector response separately, then compare live-cell localization and signaling biosensors. Quantify expression, anchor processing, membrane integrity and sensor specificity; include rescue of a depleted lipid and an independent method of perturbing the same variable. The same G protein nucleotide state can generate different outputs because membrane attachment, orientation, lipid contacts and compartmental residence determine whether a productive signaling complex can form.

prenylation covalently attaches an isoprenoid-derived lipid group to a target protein. In many signaling proteins, this helps membrane association but needs additional features to specify precise localization.

The specific five-carbon prenyl group is the alkenyl group 3-methylbut-2-en-1-yl, with connectivityHere $\mathrm{R}$ is the rest of the attached molecule; the prenyl group itself has composition ${\mathrm{C}}_5{\mathrm{H}}_9$. The ChEBI structural record uses SMILES *CC=C(C)C, with the asterisk marking the attachment point.^[ref]

The count is instructive: the attachment-end $\mathrm{C}{\mathrm{H}}_2$ contributes one carbon and two hydrogen atoms; $\mathrm{CH}$ contributes one and one; the next double-bonded carbon contributes no hydrogen; and the two methyl groups contribute two carbon and six hydrogen atoms. Together these give five carbon and nine hydrogen atoms. The double bond is one bond away from the attachment atom, connecting the prenyl group with the broader allyl group pattern.

Attaching the group through oxygen gives $\mathrm{R}-\mathrm{O}-\mathrm{C}{\mathrm{H}}_2-\mathrm{CH}=\mathrm{C}(\mathrm{C}{\mathrm{H}}_3{)}_2$, a prenyl ether; attachment through another atom gives a different linkage. The same carbon fragment therefore does not specify the whole functional group environment. In biological prenylation, the terminology can also encompass longer isoprenoid-derived attachments, so the particular transferred group must be stated.

A prenyltransferase is an enzyme that transfers a prenyl group, an isoprenoid-derived carbon group, to an acceptor. The term covers multiple reactions; the acceptor can be a small molecule rather than a protein. It should therefore not be interpreted as meaning only an enzyme for protein prenylation.

One concrete reaction joins the five-carbon dimethylallyl diphosphate and five-carbon isopentenyl diphosphate to make ten-carbon geranyl diphosphate, releasing diphosphate. Carbon counting gives $5+5=10$, while the substrate names specify the activated donors and the product structure. The official entry for this enzyme also notes poor acceptance of larger prenyl diphosphates as donors: a generic transfer label does not imply unrestricted substrate choice.^[ref]

A different example links this chemistry to Vitamin K. In 2010, Kimie Nakagawa and colleagues identified UBIAD1 as an enzyme for menaquinone-4 biosynthesis. Reducing its expression suppressed conversion of deuterium-labelled vitamin-K derivatives into labelled product; expression in insect cells restored a production system, and nuclear magnetic resonance helped identify the product.^[ref] Combining perturbation with chemical identification provides stronger evidence for an enzyme assignment than finding a similar-looking gene sequence alone.